Occult Cardiotoxicity—Toxic Effects on Cardiac Ischemic Tolerance

Toxicologic Pathology

Volumn 37, Issue 5, 2009, Pages 572-593

  Golomb, Eliahu ^a   Nyska, Abraham ^b   Schwalb, Herzl ^d  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Toxicologic Pathology   (Israel)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

3 (4,5) dimethylthiazol 2 yl) 2; 5 diphenyl tetrazolium bromide (MTT); cardioprotection; cardiotoxicity; energy metabolism; ischemia; ischemic tolerance; mitochondria; myocardial infarct

Indexed keywords

ANIMAL; DRUG EFFECT; HEART; HEART INFARCTION PREVENTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HUMAN; METABOLISM; PATHOLOGY; REVIEW; CARDIOTOXICITY; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; DIABETES MELLITUS; DRUG MECHANISM; HEART ARRHYTHMIA; HEART ATRIUM; HEART FAILURE; HEART FUNCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MITOCHONDRION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE INJURY; HEART PROTECTION; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; ISCHEMIC PRECONDITIONING; MITOCHONDRIAL PERMEABILITY; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; REOXYGENATION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; UREMIA;

ANIMALS; HEART; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL ISCHEMIA; MYOCARDIUM;

ALDEHYDE DEHYDROGENASE ISOENZYME 2; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CELL ENZYME; CHLOROACETALDEHYDE; CHLOROACETIC ACID; CONNEXIN 43; CREATINE KINASE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DELTA OPIATE RECEPTOR AGONIST; DOXORUBICIN; ESTROGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IFOSFAMIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; LACTATE DEHYDROGENASE; METFORMIN; MEVINOLIN; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE DONOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SIMVASTATIN; SULFONYLUREA; TRANSCRIPTION FACTOR; TRICHLOROETHANE; TRICHLOROETHYLENE; VINYLIDENE CHLORIDE; ZINC SULFATE;

EID: 70350451514     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/0192623309339503     Document Type: Review

References (225)

1. Ad N Schneider A Khaliulin I Borman JB Schwalb H Impaired mitochondrial response to simulated ischemic injury as a predictor of the development of atrial fibrillation after cardiac surgery: In vitro study in human myocardium J Thorac Cardiovasc Surg 2005 129 41 45
2. Ad N Snir E Vidne BA Golomb E Histologic atrial myolysis is associated with atrial fibrillation after cardiac operation Ann Thorac Surg 2001 72 688 93
3. Allard MF Schönekess BO Henning SL English DR Lopaschuk GD Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts Am J Physiol 1994 267 H742 50
4. Anderson ME Gargas ML Clewell HJI Severyn KM Quantitative evaluation of the metabolic interactions between trichloroethylene and 1,1-dichloroethylene in vivo using gas uptake methods Toxicol Appl Pharmacol 1987 89 149 57
5. Arber N Cyclooxygenase-2 inhibitors in colorectal cancer prevention: Point Cancer Epidemiol Biomarkers Prev 2008 17 1852 57
6. Ardehali H O’Rourke B Mitochondrial K(ATP) channels in cell survival and death J Mol Cell Cardiol 2005 39 7 16
7. Armstrong SC Protein kinase activation and myocardial ischemia/ reperfusion injury Cardiovasc Res 2004 61 427 36
8. Ashton KJ Nilsson U Willems L Holmgren K Headrick JP Effects of aging and ischemia on adenosine receptor transcription in mouse myocardium Biochem Biophys Res Commun 2003 312 367 72
9. Ashton KJ Willems L Holmgren K Ferreira L Headrick JP Age-associated shifts in cardiac gene transcription and transcriptional responses to ischemic stress Exp. Gerontol 2006 41 189 204
10. Atar S Ye Y Lin Y Freeberg SY Nishi SP Rosanio S Huang MH Uretsky BF Perez-Polo JR Birnbaum Y Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2 Am J Physiol 2006 290 H1960 68
11. Ausma J Litjens N Lenders MH Duimel H Mast F Wouters L Ramaekers F Allessie M Borgers M Time course of atrial fibrillation-induced cellular structural remodeling in atria of the goat J Mol Cell Cardiol 2001 33 2083 94
12. Baker JE Erythropoietin mimics ischemic preconditioning Vascul Pharmacol 2005 42 233 41
13. Banerjee A Locke-Winter C Rogers KB Mitchell MB Brew EC Cairns CB Bensard DD Harken AH Preconditioning against myocardial dysfunction after ischemia and reperfusion by an α1-adrenergic mechanism Circ Res 1993 73 656 70
14. Batist G Mersereau W Malashenko BA Chiu RC Response to ischemia-reperfusion injury in hypertrophic heart. Role of free-radical metabolic pathways Circulation 1989 80 III 10 III 13
15. Baxter GF Goma FM Yellon DM Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardium Br J Pharmacol 1995 115 222 24
16. Bell RM Yellon DM Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway J Am Coll Cardiol 2003a 41 508 15
17. Bell RM Yellon DM Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: The role of PI3K, Akt and eNOS J Mol Cell Cardiol 2003b 35 185 93
18. Berthiaume JM Wallace KB Adriamycin-induced oxidative mitochondrial cardiotoxicity Cell Biol Toxicol 2006 23 15 25
19. Besík J Szárszoi O Kunes J Netuka I Malý J Kolár F Pirk J Ostádal B Tolerance to acute ischemia in adult male and female spontaneously hypertensive rats Physiol Res 2007 56 267 74
20. Bilinska M Potocka J Korzeniowska-Kubacka I Piotrowicz R “Warm-up” phenomenon in diabetic patients with stable angina treated with diet or sulfonylureas” Coron Artery Dis 2007 18 455 62
21. Bishop JB Tani Y Witt K Johnson JA Peddada S Dunnick J Nyska A Mitochondrial damage revealed by morphometric and semiquantitative analysis of mouse pup cardiomyocytes following in utero and postnatal exposure to zidovudine and lamivudine Toxicol Sci 2004 81 512 17
22. Boengler K Schulz R Heusch G Connexin 43 signalling and cardioprotection Heart 2006 92 1724 27
23. Bolli R Preconditioning: A paradigm shift in the biology of myocardial ischemia Am J Physiol 2007 292 H19 27
24. Boutros A Wang J Ischemic preconditioning, adenosine and bethanechol protect spontaneously hypertensive isolated rat hearts J Pharmacol Exp Ther 1995 275 1148 56
25. Bril A Forest MC Gout B Ischemia and reperfusion-induced arrhythmias in rabbits with chronic heart failure Am J Physiol 1991 261 H301 7
26. Buchwald A Till H Unterberg C Oberschmidt R Figulla HR Wiegand V Alterations of the mitochondrial respiratory chain in human dilated cardiomyopathy Eur Heart J 1990 11 509 16
27. Budas GR Churchill EN Mochly-Rosen D Cardioprotective mechanisms of PKC isozyme-selective activators and inhibitors in the treatment of ischemia-reperfusion injury Pharmacol Res 2007 55 523 36
28. Bullard AJ Govewalla P Yellon DM Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo Basic Res Cardiol 2005 100 397 403
29. Butler KL Huang AH Gwathmey JK AT1–receptor blockade enhances ischemic preconditioning in hypertrophied rat myocardium Am J Physiol 1999 277 H2482 87
30. Chakko S de Marchena E Kessler KM Myerburg RJ Ventricular arrhythmias in congestive heart failure Clin Cardiol 1989 12 525 30
31. Chan AW Bhatt DL Chew DP Quinn MJ Moliterno DJ Topol EJ Ellis SG Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention Circulation 2002 105 691 96
32. Chen CH Budas GR Churchill EN Disatnik MH Hurley TD Mochly-Rosen D Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart Science 2008 321 1493 95
33. Chen CH Gray MO Mochly-Rosen D Cardioprotection from ischemia by a brief exposure to physiological levels of ethanol: Role of epsilon protein kinase C Proc Natl Acad Sci USA 1999 96 12784 89
34. Clarke SJ Khaliulin I Das M Parker JE Heesom KJ Halestrap AP Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation Circ Res 2008 102 1082 90
35. Cleveland JC Jr Meldrum DR Cain BS Banerjee A Harken AH Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited Circulation 1997 96 29 32
36. Cornelussen RN Garnier AV Vork MM Geurten P Reneman RS van der Vusse GJ Snoeckx LH Heat stress protects aged hypertrophied and nonhypertrophied rat hearts against ischemic damage Am J Physiol 1997 273 H1333 41
37. Cornelussen R Spiering W Webers JH De Bruin LG Reneman RS van der Vusse GJ Snoeckx LH Heat shock improves ischemic tolerance of hypertrophied rat hearts Am J Physiol 1994 267 H1941 47
38. Crompton M The mitochondrial permeability transition pore and its role in cell death Biochem J 1999 341 233 49
39. Currie RW Tanguay RM Kingma JG Jr Heat-shock response and limitation of tissue necrosis during occlusion/reperfusion in rabbit hearts Circulation 1993 87 963 71
40. Del Monte F Hajjar RJ Intracellular devastation in heart failure Heart Fail Rev 2008 13 151 62
41. Diaz RJ Wilson GJ Selective blockade of AT1 angiotensin II receptors abolishes ischemic preconditioning in isolated rabbit hearts J Mol Cell Cardiol 1997 29 129 39
42. Dikow R Kihm LP Zeier M Kapitza J Törnig J Amann K Tiefen-bacher C Ritz E Increased infarct size in uremic rats: Reduced ischemia tolerance? J Am Soc Nephrol 2004 15 1530 36
43. Di Napoli P Antonio Taccardi A Grilli A Spina R Felaco M Barsotti A De Caterina R Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: An ex vivo study in isolated working rat hearts Cardiovasc Res 2001 51 283 93
44. Doenst T Guthrie PH Chemnitius JM Zech R Taegtmeyer H Fasting, lactate, and insulin improve ischemia tolerance in rat heart: A comparison with ischemic preconditioning Am J Physiol 1996 270 H1607 15
45. Dotani MI Elnicki DM Jain AC Gibson CM Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting Am J Cardiol 2000 86 1128 30
46. Dunnick J Blackshear P Kissling G Cunningham M Parker J Nyska A Critical pathways in heart function: Bis(2-chloroeth-oxy)methane-induced heart gene transcript change in F344 rats Toxicol Pathol 2006 34 348 56
47. Dunnick J Johnson JA Horton J Nyska A Bis(2–chloroethoxy) methane-induced mitochondrial and myofibrillar damage: Short-term time-course study Toxicol Sci 2004 81 243 52
48. Dworschak M Breukelmann D Hannon JD The impact of isoflurane during simulated ischemia/reoxygenation on intracellular calcium, contractile function, and arrhythmia in ventricular myocytes Anesth Analg 2004 99 1302 7
49. Ebrahim Z Yellon DM Baxter GF Attenuated cardioprotective response to bradykinin, but not classical ischaemic preconditioning, in DOCA-salt hypertensive left ventricular hypertrophy Pharmacol Res 2007a 55 42 48
50. Ebrahim Z Yellon DM Baxter GF Ischemic preconditioning is lost in aging hypertensive rat heart: Independent effects of aging and longstanding hypertension Exp Gerontol 2007b 42 807 14
51. Elmore S Apoptosis: A review of programmed cell death Toxicol Pathol 2007 35 495 516
52. Evans JM Ogston SA Emslie-Smith A Morris AD Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: A comparison of patients treated with sulfonylureas and metformin Diabetologia 2006 49 930 36
53. Ferdinandy P Schulz R Baxter GF Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning Pharmacol Rev 2007 59 418 58
54. Ferreira BM Moffa PJ Falcão A Uchida A Camargo P Pereyra P Soares PR Hueb W Ramires JA The effects of glibenclamide, a K-ATP channel blocker, on the warm-up phenomenon Ann Noninvasive Electrocardiol 2005 10 356 62
55. Forrat R Sebbag L Wiernsperger N Guidollet J Renaud S de Lorgeril M Acute myocardial infarction in dogs with experimental diabetes Cardiovasc Res 1993 27 1908 12
56. Franke TF Hornik CP Segev L Shostak GA Sugimoto C PI3K/Akt and apoptosis: Size matters Oncogene 2003 22 8983 98
57. Friehs I del Nido PJ Increased susceptibility of hypertrophied hearts to ischemic injury Ann Thorac Surg 2003 75 S678 84
58. Fryer RM Hsu AK Nagase H Gross GJ Opioid-induced cardioprotection against myocardial infarction and arrhythmias: Mitochondrial versus sarcolemmal ATP-sensitive potassium channels J Pharmacol Exp Ther 2000 294 451 57
59. Gaasch WH Zile MR Hoshino PK Weinberg EO Rhodes DR Apstein CS Tolerance of the hypertrophic heart to ischemia. Studies in compensated and failing dog hearts with pressure overload hypertrophy Circulation 1990 81 1644 53
60. Garlid KD Dos Santos P Xie ZJ Costa AD Paucek P Mitochondrial K(+) transport: The role of the mitochondrial ATP-sensitive K(+) channel in cardiac function and cardioprotection Biochim Biophys Acta 2003 1606 1 21
61. Garlid KD Paucek P Yarov-Yarovoy V Murray HN Darbenzio RB D’Alonzo AJ Lodge NJ Smith MA Grover GJ Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection Circ Res 1997 81 1072 82
62. Ghosh S Standen NB Galiñanes M Evidence for mitochondrial K ATP channels as effectors of human myocardial preconditioning Cardiovasc Res 2000a 45 934 40
63. Ghosh S Standen NB Galiñanes M Preconditioning the human myocardium by simulated ischemia: Studies on the early and delayed protection Cardiovasc Res 2000b 45 339 50
64. Ghosh S Standen NB Galiñanes M Failure to precondition pathological human myocardium J Am Coll Cardiol 2001 37 711 18
65. Girod WG Jones SP Sieber N Aw TY Lefer DJ Effects of hypercholesterolemia on myocardial ischemia-reperfusion injury in LDL receptor-deficient mice Arterioscler Thromb Vasc Biol 1999 19 2776 81
66. Golomb E Schneider A Houminer E Dunnick J Kissling G Borman JB Nyska A Schwalb H Occult cardiotoxicity: Subtoxic dosage of Bis(2–chloroethoxy)methane impairs cardiac response to simulated ischemic injury Toxicol Pathol 2007 35 383 87
67. Green T Hathway DE The biological fate in rats of vinyl chloride in relation to its oncogenicity Chem Biol Interact 1975 11 545 62
68. Gross GJ ATP-sensitive potassium channels and myocardial preconditioning Basic Res Cardiol 1995 90 85 88
69. Gross GJ Auchampach JA Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs Circ Res 1992 70 223 33
70. Gross GJ Fryer RM Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning Circ Res 1999 84 973 79
71. Grover GJ D’Alonzo AJ Sleph PG Dzwonczyk S Hess TA Darbenzio RB The cardioprotective and electrophysiological effects of cromakalim are attenuated by meclofenamate through a cyclooxygenase-independent mechanism J Pharmacol Exp Ther 1994 269 536 40
72. Guzy RD Hoyos B Robin E Chen H Liu L Mansfield KD Simon MC Hammerling U Schumacker PT Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing Cell Metab 2005 1 401 8
73. Hagar JM Hale SL Kloner RA Effect of preconditioning ischemia on reperfusion arrhythmias after coronary artery occlusion and reperfusion in the rat Circ Res 1991 68 61 68
74. Hale SL Birnbaum Y Kloner RA Estradiol, administered acutely, protects ischemic myocardium in both female and male rabbits J Cardiovasc Pharmacol Ther 1997 2 47 52
75. Hale SL Kloner RA Protection of myocardium by transient, preischemic administration of phenylephrine in the rabbit Coron Artery Dis 1994 5 605 10
76. Halestrap AP Clarke SJ Javadov SA Mitochondrial permeability transition pore opening during myocardial reperfusion—A target for cardioprotection Cardiovasc Res 2004 61 372 85
77. Hamilton KL Powers SK Sugiura T Kim S Lennon S Tumer N Mehta JL Short-term exercise training can improve myocardial tolerance to I/R without elevation in heat shock proteins Am J Physiol Heart Circ Physiol 2001 281 H1346 52
78. Hansel TT Kharitonov SA Donnelly LE Erin EM Currie MG Moore WM Manning PT Recker DP Barnes PJ A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics FASEB J 2003 17 1298 1300
79. Harel Z Cyclooxygenase-2 specific inhibitors in the treatment of dysmenorrhea J Pediatr Adolesc Gynecol 2004 17 75 79
80. Hassouna A Loubani M Matata BM Fowler A Standen NB Galiñanes M Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium Cardiovasc Res 2006 69 450 58
81. Hassouna A Matata BM Galiñanes M PKC-ɛ is upstream and PKC-α is downstream of mito-K-ATP channels in the signal transduction pathway of ischemic preconditioning of human myocardium Am J Physiol 2004 287 C1418 25
82. Hattori R Otani H Maulik N Das DK Pharmacological preconditioning with resveratrol: Role of nitric oxide Am J Physiol 2002 282 H1988 95
83. Hausenloy DJ Tsang A Mocanu MM Yellon DM Ischemic preconditioning protects by activating prosurvival kinases at reperfusion Am J Physiol 2005 288 H971 76
84. Hausenloy DJ Yellon DM New directions for protecting the heart against ischaemia-reperfusion injury: Targeting the Reperfusion Injury Salvage Kinase (RISK)-Pathway Cardiovasc Res 2004 61 448 60
85. Hausenloy DJ Yellon DM Survival kinases in ischemic preconditioning and postconditioning Cardiovasc Res 2006 70 240 53
86. Holmuhamedov EL Jovanović S Dzeja PP Jovanović A Terzic A Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function Am J Physiol 1998 275 H1567 76
87. Hoskins DE Ignasiak DP Saganek LJ Gallagher KP Peterson JT Myocardial infarct size is smaller in dogs with pacing-induced heart failure Cardiovasc Res 1996 32 238 47
88. Hropot M Grötsch H Klaus E Langer KH Linz W Wiemer G Schölkens BA Ramipril prevents the detrimental sequels of chronic NO synthase inhibition in rats: Hypertension, cardiac hypertrophy and renal insufficiency Naunyn Schmiedebergs Arch Pharmacol 1994 350 646 52
89. Huss JM Kelly DP Mitochondrial energy metabolism in heart failure: A question of balance J Clin Invest 2005 115 547 55
90. Iliodromitis EK Zoga A Vrettou A Andreadou I Paraskevaidis IA Kaklamanis L Kremastinos DT The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits Atherosclerosis 2006 188 356 62
91. Imagawa J Yellon DM Baxter GF Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning Br J Pharmacol 1999 126 701 8
92. Inou T Lamberth WC Jr Koyanagi S Harrison DG Eastham CL Marcus ML Relative importance of hypertension after coronary occlusion in chronic hypertensive dogs with LVH Am J Physiol 1987 253 H1148 58
93. Jaberansari MT Baxter GF Muller CA Latouf SE Röth E Opie LH Yellon DM Angiotensin-converting enzyme inhibition enhances a subthreshold stimulus to elicit delayed preconditioning in pig myocardium J Am Coll Cardiol 2001 37 1996 2001
94. Jain NB Potula V Schwartz J Vokonas PS Sparrow D Wright RO Nie H Hu H Lead levels and ischemic heart disease in a prospective study of middle-aged and elderly men: The VA Normative Aging Study Environ Health Perspect 2007 115 871 75
95. Janse MJ Wit AL Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction Physiol Rev 1989 69 1049 169
96. Jonassen AK Sack MN Mjøs OD Yellon DM Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling Circ Res 2001 89 1191 98
97. Jones BK Hathway DE Differences in metabolism of vinylidene chloride between mice and rats Br J Cancer 1978 37 411 17
98. Joqueviel C Malet-Marino M Martino R A 13C NMR study of 2-(13)C-chloroacetaldehyde, a metabolite of ifosfamide and cyclophosphamide, in the isolated perfused rabbit heart model. Initial observations on its cardiotoxicity and cardiac metabolism Cell Mol Biol 1997 43 773 82
99. Juhaszova M Zorov DB Kim SH Pepe S Fu Q Fishbein KW Ziman BD Wang S Ytrehus K Antos CL Olson EN Sollott SJ Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore J Clin Invest 2004 113 1535 49
100. Jung O Jung W Malinski T Wiemer G Schoelkens BA Linz W Ischemic preconditioning and infarct mass: The effect of hypercholesterolemia and endothelial dysfunction Clin Exp Hypertens 2000 22 165 79
101. Kang YJ Molecular and cellular mechanisms of cardiotoxicity Environ Health Perspect 2001 109 Suppl 1 27 34
102. Kita H Miura T Miki T Genda S Tanno M Fukuma T Shimamoto K Infarct size limitation by bradykinin receptor activation is mediated by the mitochondrial but not by the sarcolemmal K(ATP) channel Cardiovasc Drugs Ther 2000 14 497 502
103. Kloner RA Dow J Bhandari A Postconditioning markedly attenuates ventricular arrhythmias after ischemia-reperfusion J Cardiovasc Pharmacol Ther 2006 11 55 63
104. Kocić I Konstański Z Kaminski M Dworakowska D Dworakowski R Experimental hyperlipidemia prevents the protective effect of ischemic preconditioning on the contractility and responsiveness to phenylephrine of rat-isolated stunned papillary muscle Gen Pharmacol 1999 33 213 19
105. Kocsis GF Pipis J Fekete V Kovács-Simon A Odendaal L Molnár E Giricz Z Janáky T van Rooyen J Csont T Ferdinandy P Lovastatin interferes with the infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts Am J Physiol 2008 294 H2406 9
106. Kohya T Yokoshiki H Tohse N Kanno M Nakaya H Saito H Kitabatake A Regression of left ventricular hypertrophy prevents ischaemia-induced lethal arrhythmias: Beneficial effect of angio-tensin II blockade Circ Res 1995 76 892 99
107. Koyanagi S Eastham CL Harrison DG Marcus ML Increased size of myocardial infarction in dogs with chronic hypertension and left ventricular hypertrophy Circ Res 1982 50 55 62
108. Kremastinos DT Bofilis E Karavolias GK Papalois A Kaklamanis L Iliodromitis EK Preconditioning limits myocardial infarct size in hypercholesterolemic rabbits Atherosclerosis 2000 150 81 89
109. Kristiansen SB Løfgren B Støttrup NB Khatir D Nielsen-Kudsk JE Nielsen TT Bøtker HE Flyvbjerg A Ischaemic preconditioning does not protect the heart in obese and lean animal models of type 2 diabetes Diabetologia 2004 47 1716 21
110. Kukreja RC Salloum F Das A Ockaili R Yin C Bremer YA Fisher PW Wittkamp M Hawkins J Chou E Kukreja AK Wang X Marwaha VR Xi L Pharmacological preconditioning with sildenafil: Basic mechanisms and clinical implications Vascul Pharmacol 2005 42 219 32
111. Kyriakides ZS Psychari S Iliodromitis EK Kolettis TM Sbarouni E Kremastinos DT Hyperlipidemia prevents the expected reduction of myocardial ischemia on repeated balloon inflations during angioplasty Chest 2002 121 1211 15
112. Lange SA Wolf B Schober K Wunderlich C Marquetant R Wein-brenner C Strasser RH Chronic angiotensin II receptor blockade induces cardioprotection during ischemia by increased PKC-epsilon expression in the mouse heart J Cardiovasc Pharmacol 2007 49 46 55
113. Lee TM Chou TF Impairment of myocardial protection in type 2 diabetic patients J Clin Endocrinol Metab 2003 88 531 37
114. Lendeckel U Müller C Röcken C Laube B Täger M Huth C Klein HU Goette A Expression of opioid receptor subtypes and their ligands in fibrillating human atria Pacing Clin Electrophysiol 2005 28 Suppl 1 S275 9
115. Levy D Garrison RJ Savage DD Kannel WB Castelli WP Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study N Engl J Med 1990 322 1561 66
116. Lévy S Sbragia P Remodelling in atrial fibrillation Arch Mal Coeur Vaiss 2005 98 308 12
117. Li G Tokuno S Tähep ldP Vaage J Löwbeer C Valen G Preconditioning protects the severely atherosclerotic mouse heart Ann Thorac Surg 2001 71 1296 1303
118. Liem DA te Lintel Hekkert M Manintveld OC Boomsma F Verdouw PD Duncker DJ Myocardium tolerant to an adenosine-dependent ischemic preconditioning stimulus can still be protected by stimuli that employ alternative signaling pathways Am J Physiol 2005 288 H1165 72
119. Lin PH Lee SH Su CP Wei YH Oxidative damage to mitochondrial DNA in atrial muscle of patients with atrial fibrillation Free Radic Biol Med 2003 35 1310 18
120. Lindenauer PK Pekow P Wang K Gutierrez B Benjamin EM Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery JAMA 2004 291 2092 99
121. Linz W Wiemer G Schmidts HL Ulmer W Ruppert D Schölkens BA ACE inhibition decreases postoperative mortality in rats with left ventricular hypertrophy and myocardial infarction Clin Exp Hypertens 1996 18 691 712
122. Liu GS Thornton J Van Winkle DM Stanley AW Olsson RA Downey JM Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart Circulation 1991 84 350 56
123. Liu Y Sato T O’Rourke B Marban E Mitochondrial ATP-dependent potassium channels: Novel effectors of cardioprotection? Circulation 1998 97 2463 69
124. Liu Y Thornton JD Cohen MV Downey JM Schaffer SW Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction Circulation 1993 88 1273 78
125. Liu Y Tsuchida A Cohen MV Downey JM Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts J Mol Cell Cardiol 1995 27 883 92
126. Lochner A Genade S Moolman JA Ischemic preconditioning: Infarct size is a more reliable endpoint than functional recovery Basic Res Cardiol 2003 98 337 46
127. Long P Nguyen Q Thurow C Broderick TL Caloric restriction restores the cardioprotective effect of preconditioning in the rat heart Mech Ageing Dev 2002 123 1411 13
128. Loubani M Fowler A Standen NB Galiñanes M The effect of gliclazide and glibenclamide on preconditioning of the human myocardium Eur J Pharmacol 2005 515 142 49
129. Loubani M Galiñanes M α1-adrenoceptors during simulated ischemia and reoxygenation of the human myocardium: Effect of the dose and time of administration J Thorac Cardiovasc Surg 2001 122 103 12
130. Loubani M Galiñanes M Long-term administration of nicorandil abolishes ischemic and pharmacologic preconditioning of the human myocardium: Role of mitochondrial adenosine triphosphate-dependent potassium channels J Thorac Cardiovasc Surg 2002a 124 750 57
131. Loubani M Galiñanes M Pharmacological and ischemic preconditioning of the human myocardium: MitoK(ATP) channels are upstream and p38MAPK is downstream of PKC BMC Physiol 2002b 2 10
132. Loubani M Ghosh S Galiñanes M The aging human myocardium: Tolerance to ischemia and responsiveness to ischemic preconditioning J Thorac Cardiovasc Surg 2003 126 143 47
133. Loubani M Hassouna A Galiñanes M Delayed preconditioning of the human myocardium: Signal transduction and clinical implications Cardiovasc Res 2004 61 600 609
134. Ma G Al-Shabrawey M Johnson JA Datar R Tawfik HE Guo D Caldwell RB Caldwell RW Protection against myocardial ischemia/reperfusion injury by short-term diabetes: Enhancement of VEGF formation, capillary density, and activation of cell survival signaling Naunyn Schmiedebergs Arch Pharmacol 2006 373 415 27
135. MacDonald AC Howlett SE Differential effects of the sodium calcium exchange inhibitor, KB-R7943, on ischemia and reperfusion injury in isolated guinea pig ventricular myocytes Eur J Pharmacol 2008 580 214 23
136. Mancardi D Tullio F Crisafulli A Rastaldo R Folino A Penna C Pagliaro P Omega 3 has a beneficial effect on ischemia/reperfusion injury, but can not reverse the effect of stressful forced exercise Nutr Metab Cardiovasc Dis 2009 19 20 26
137. Marber MS Latchman DS Walker JM Yellon DM Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction Circulation 1993 88 1264 72
138. Margonato V Milano G Allibardi S Merati G de Jonge R Samaja M Swim training improves myocardial resistance to ischemia in rats Int J Sports Med 2000 21 163 67
139. Mariani J Ou R Bailey M Rowland M Nagley P Rosenfeldt F Pepe S Tolerance to ischemia and hypoxia is reduced in aged human myocardium J Thorac Cardiovasc Surg 2000 120 660 67
140. Matejíková J Kucharská J Pintérová M Pancza D Ravingerová T Protection against ischaemia-induced ventricular arrhythmias and myocardial dysfunction conferred by preconditioning in the rat heart: Involvement of mitochondrial K(ATP) channels and reactive oxygen species Physiol Res 2009 58 9 19
141. Matheson AJ Figgitt DP Rofecoxib: A review of its use in the management of osteoarthritis, acute pain and rheumatoid arthritis Drugs 2001 61 833 65
142. Matsusaka H Ide T Matsushima S Ikeuchi M Kubota T Sunagawa K Kinugawa S Tsutsui H Targeted deletion of p53 prevents cardiac rupture after myocardial infarction in mice Cardiovasc Res 2006 70 457 65
143. McLeod CJ Pagel I Sack MN The mitochondrial biogenesis regulatory program in cardiac adaptation to ischemia—A putative target for therapeutic intervention Trends Cardiovasc Med 2005 15 118 23
144. Miki T Miura T Tanno M Sakamoto J Kuno A Genda S Matsumoto T Ichikawa Y Shimamoto K Interruption of signal transduction between G protein and PKC-epsilon underlies the impaired myocardial response to ischemic preconditioning in postinfarct remodeled hearts Mol Cell Biochem 2003 247 185 93
145. Miki T Miura T Tsuchida A Nakano A Hasegawa T Fukuma T Shimamoto K Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation Circulation 2000 102 458 63
146. Mocanu MM Baxter GF Yue Y Critz SD Yellon DM The p38 MAPK inhibitor, SB203580, abrogates ischaemic preconditioning in rat heart but timing of administration is critical Basic Res Cardiol 2000 95 472 78
147. Mocanu MM Bell RM Yellon DM PI3 kinase and not p42/ p44 appears to be implicated in the protection conferred by ischemic preconditioning J Mol Cell Cardiol 2002 34 661 68
148. Mocanu MM Yellon DM PTEN, the Achilles’ heel of myocardial ischaemia/reperfusion injury? Br J Pharmacol 2007 150 833 38
149. Mühlfeld C Urru M Rümelin R Mirzaie M Schöndube F Richter J Dörge H Myocardial ischemia tolerance in the newborn rat involving opioid receptors and mitochondrial k+ channels Anat Rec 2006 288 297 303
150. Müller N Riedel M Schwarz MJ Psychotropic effects of COX-2 inhibitors—A possible new approach for the treatment of psychiatric disorders Pharmacopsychiatry 2004 37 266 69
151. Munch-Ellingsen J Løkebø JE Bugge E Jonassen AK Ravingerová T Ytrehus K 5–HD abolishes ischemic preconditioning independently of mono-phasic action potential duration in the heart Basic Res Cardiol 2000 95 228 34
152. Murry CE Jennings RB Reimer KA Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium Circulation 1986 74 1124 36
153. Nakano A Miura T Miki T Nozawa Y Ichikawa Y Ura N Shimamoto K Effects of neutral endopeptidase 24.11 inhibition on myocardial infarct size and ischemic preconditioning in rabbits Naunyn Schmiedebergs Arch Pharmacol 2002 366 335 42
154. Nemoto S Takeda K Yu ZX Ferrans VJ Finkel T Role for mitochondrial oxidants as regulators of cellular metabolism Mol Cell Biol 2000 20 7311 18
155. O’Brien JD Ferguson JH Howlett SE Effects of ischemia and reperfusion on isolated ventricular myocytes from young adult and aged Fischer 344 rat hearts Am J Physiol 2008 294 H2174 83
156. Ovelgönne JH Van Wijk R Verkleij AJ Post JA Cultured neonatal rat heart cells can be preconditioned by ischemia, but not by heat shock. The role of stress proteins J Mol Cell Cardiol 1996 28 1617 29
157. Pasceri V Patti G Nusca A Pristipino C Richichi G Di Sciascio G Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: Results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) Study Circulation 2004 110 674 78
158. Peart JN Headrick JP Sustained cardioprotection: Exploring unconventional modalities Vascul Pharmacol 2008 49 63 70
159. Ping P Murphy E Role of p38 mitogen-activated protein kinases in preconditioning: A detrimental factor or a protective kinase? Circ Res 2000 86 921 22
160. Pomerantz BJ Robinson TN Morrell TD Heimbach JK Banerjee A Harken AH Selective mitochondrial adenosine triphosphate-sensitive potassium channel activation is sufficient to precondition human myocardium J Thorac Cardiovasc Surg 2000 120 387 92
161. Przyklenk K Maynard M Darling CE Whittaker P Aging mouse hearts are refractory to infarct size reduction with postconditioning J Am Coll Cardiol 2008 51 1393 98
162. Quast U Stephan D Bieger S Russ U The impact of ATP-sensitive K+ channel subtype selectivity of insulin secretagogues for the coronary vasculature and the myocardium Diabetes 2004 53 Suppl 3 S156 64
163. Rajesh KG Sasaguri S Zhitian Z Suzuki R Asakai R Maeda H Second window of ischemic preconditioning regulates mitochondrial permeability transition pore by enhancing Bcl-2 expression Cardiovasc Res 2003 59 297 307
164. Randall MD Gardiner SM Bennett T Enhanced cardiac preconditioning in the isolated heart of the transgenic ((mREN-2) 27) hypertensive rat Cardiovasc Res 1997 33 400 409
165. Ravingerová T Intrinsic defensive mechanisms in the heart: A potential novel approach to cardiac protection against ischemic injury Gen Physiol Biophys 2007 26 3 13
166. Ravingerová T Neckár J Kolár F Ischemic tolerance of rat hearts in acute and chronic phases of experimental diabetes Mol Cell Biochem 2003 249 167 74
167. Ravingerová T Pancza D Ziegelhoffer A Styk J Preconditioning modulates susceptibility to ischemia-induced arrhythmias in the rat heart: The role of α-adrenergic stimulation and K(ATP) channels Physiol Res 2002 51 109 19
168. Ravingerová T Stetka R Pancza D Ulicná O Ziegelhöffer A Styk J Susceptibility to ischemia-induced arrhythmias and the effect of preconditioning in the diabetic rat heart Physiol Res 2000 49 607 16
169. Reimer KA Murry CE Yamasawa I Hill ML Jennings RB Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis Am J Physiol 1986 251 H1306 15
170. Sack MN Mitochondrial depolarization and the role of uncoupling proteins in ischemia tolerance Cardiovasc Res 2006 72 210 19
171. Sack MN Kelly DP The energy substrate switch during development of heart failure: Gene regulatory mechanisms Int J Mol Med 1998 1 17 24
172. Sato T O’Rourke B Marbán E Modulation of mitochondrial ATP-dependent K+ channels by protein kinase C Circ Res 1998 83 110 14
173. Sato T Sasaki N Seharaseyon J O’Rourke B Marbán E Selective pharmacological agents implicate mitochondrial but not sarcolemmal K(ATP) channels in ischemic cardioprotection Circulation 2000 101 2418 23
174. Schneider A Ad N Izhar U Khaliulin I Borman JB Schwalb H Protection of myocardium by cyclosporin A and insulin: In vitro simulated ischemia study in human myocardium Ann Thorac Surg 2003 76 1240 45
175. Schott RJ Rohmann S Braun ER Schaper W Ischemic preconditioning reduces infarct size in swine myocardium Circ Res 1990 66 1133 42
176. Schulman D Latchman DS Yellon DM Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury Am J Physiol 2001 281 H1630 36
177. Schultz JE Hsu AK Barbieri JT Li PL Gross GJ Pertussis toxin abolishes the cardioprotective effect of ischemic preconditioning in intact rat heart Am J Physiol 1998 275 H495 500
178. Schulz R Boengler K Totzeck A Luo Y Garcia-Dorado D Heusch G Connexin 43 in ischemic pre- and postconditioning Heart Fail Rev 2007 12 261 66
179. Schwartz DR Sack MN Targeting the mitochondria to augment myocardial protection Curr Opin Pharmacol 2008 8 160 65
180. Seccia TM Atlante A Vulpis V Marra E Passarella S Pirrelli A Mitochondrial energy metabolism in the left ventricular tissue of spontaneously hypertensive rats: Abnormalities in both ade-ninenucleotide and phosphate translocators and enzyme adenylate-kinase and creatine-phosphokinase activities Clin Exp Hypertens 1998 20 345 58
181. Sharma A Singh M Role of angiotensin in cardioprotective effect of ischemic preconditioning J Cardiovasc Pharmacol 1999 33 772 78
182. Shinmura K Bolli R The risk for myocardial infarction with cyclooxygenase-2 inhibitors Ann Intern Med 2005 143 617 18
183. Shinmura K Tang XL Wang Y Xuan YT Liu SQ Takano H Bhatnagar A Bolli R Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits Proc Natl Acad Sci USA 2000 97 10197 202
184. Shinmura K Tamaki K Bolli R Short-term caloric restriction improves ischemic tolerance independent of opening of ATP-sensitive K+ channels in both young and aged hearts J Mol Cell Cardiol 2005 39 285 96
185. Shinmura K Tamaki K Bolli R Impact of 6–mo caloric restriction on myocardial ischemic tolerance: Possible involvement of nitric oxide-dependent increase in nuclear Sirt1 Am J Physiol 2008 295 H2348 55
186. Simm A Friedrich I Scheubel RJ Gursinsky T Silber RE Bartling B Age dependency of the cariporide-mediated cardio-protection after simulated ischemia in isolated human atrial heart muscles Exp Gerontol 2008 43 691 99
187. Simoons ML Boersma E Maas AC Deckers JW Management of myocardial infarction: The proper priorities Eur Heart J 1997 18 896 99
188. Steenbergen C The role of p38 mitogen-activated protein kinase in myocardial ischemia/reperfusion injury; relationship to ischemic preconditioning Basic Res Cardiol 2002 97 276 85
189. Sun JZ Tang XL Knowlton AA Park SW Qiu Y Bolli R Late preconditioning against myocardial stunning. An endogenous protective mechanism that confers resistance to postischemic dysfunction 24 h after brief ischemia in conscious pigs J Clin Invest 1995 95 388 403
190. Swerdlow AJ Higgins CD Smith P Cunningham D Hancock BW Horwich A Hoskin PJ Lister A Radford JA Rohatiner AZ Linch DC Myocardial infarction mortality risk after treatment for Hodgkin disease: A collaborative British cohort study J Natl Cancer Inst 2007 99 206 14
191. Szilvassy Z Ferdinandy P Szilvassy J Nagy I Karcsu S Lonovics J Dux L Koltai M The loss of pacing-induced preconditioning in atherosclerotic rabbits: Role of hypercholesterolaemia J Mol Cell Cardiol 1995 27 2559 69
192. Takano H Tang XL Kodani E Bolli R Late preconditioning enhances recovery of myocardial function after infarction in conscious rabbits Am J Physiol 2000 279 H2372 81
193. Tavackoli S Ashitkov T Hu ZY Motamedi M Uretsky BF Birnbaum Y Simvastatin-induced myocardial protection against ischemia-reperfusion injury is mediated by activation of ATP-sensitive K+ channels Coron Artery Dis 2004 15 53 58
194. Thornton JD Liu GS Downey JM Pretreatment with pertussis toxin blocks the protective effects of preconditioning: Evidence for a G-protein mechanism J Mol Cell Cardiol 1993 25 311 20
195. Tong H Imahashi K Steenbergen C Murphy E Phosphorylation of glycogen synthase kinase-3β during preconditioning through a phosphatidyl-inositol-3–kinase-dependent pathway is cardioprotective Circ Res 2002 90 377 79
196. Tosaki A Behjet NS Engelman DT Engelman RM Das DK Alpha-1 adrenergic receptor agonist-induced preconditioning in isolated working rat hearts J Pharmacol Exp Ther 1995 273 689 94
197. Tosaki A Engelman DT Engelman RM Das DK The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts Cardiovasc Res 1996 31 526 36
198. Ueda Y Kitakaze M Komamura K Minamino T Asanuma H Sato H Kuzuya T Takeda H Hori M Pravastatin restored the infarct size-limiting effect of ischemic preconditioning blunted by hypercholesterolemia in the rabbit model of myocardial infarction J Am Coll Cardiol 1999 34 2120 25
199. Umar A Viner JL Anderson WF Hawk ET Development of COX inhibitors in cancer prevention and therapy Am J Clin Oncol 2003 26 S48 57
200. Ungi I Ungi T Ruzsa Z Nagy E Zimmermann Z Csont T Ferdinandy P Hypercholesterolemia attenuates the anti-ischemic effect of preconditioning during coronary angioplasty Chest 2005 128 1623 28
201. Vegh A Komori S Szekeres L Parratt JR Antiarrhythmic effects of pre-conditioning in anaesthetised dogs and rats Cardiovasc Res 1992 26 487 95
202. Vegh A Parratt JR Noradrenaline, infused locally, reduces arrhythmia severity during coronary artery occlusion in anaesthetised dogs Cardiovasc Res 2002 55 53 63
203. Vegh A Szekeres L Parratt JR Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs Br J Pharmacol 1991a 104 294 95
204. Vegh A Szekeres L Parratt JR Transient ischaemia induced by rapid cardiac pacing results in myocardial preconditioning Cardiovasc Res 1991b 25 1051 53
205. Vegh A Szekeres L Parratt J Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway Br J Pharmacol 1992 107 648 52
206. Venardos K Ashton K Headrick J Perkins A Effects of dietary selenium on post-ischemic expression of antioxidant mRNA Mol Cell Biochem 2005 270 131 38
207. Visarius TM Bahler H Kupfer MA Cerny T Lauterburg BH Thiodiglycolic acid is excreted by humans receiving ifosfamide and inhibits mitochondrial function in rats Drug Metab Disp 1998 26 193 96
208. Vousden KH Lane DP p53 in health and disease Nat Rev Mol Cell Biol 2007 8 275 83
209. Wallenborn JG Evansky P Shannahan JH Vallanat B Ledbetter AD Schladweiler MC Richards JH Gottipolu RR Nyska A Kodavanti UP Subchronic inhalation of zinc sulfate induces cardiac changes in healthy rats Toxicol Appl Pharmacol 2008 232 69 77
210. Wayman NS Ellis BL Thiemermann C Simvastatin reduces infarct size in a model of acute myocardial ischemia and reperfusion in the rat Med Sci Monit 2003 9 BR155 59
211. Wijffels MC Kirchhof CJ Dorland R Allessie MA Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats Circulation 1995 92 1954 68
212. Willems L Ashton KJ Headrick JP Adenosine-mediated cardioprotection in the aging myocardium Cardiovasc Res 2005 66 245 55
213. Willems L Garnham B Headrick JP Aging-related changes in myocardial purine metabolism and ischemic tolerance Exp Gerontol 2003 38 1169 77
214. Willems L Zatta A Holmgren K Ashton KJ Headrick JP Age-related changes in ischemic tolerance in male and female mouse hearts J Mol Cell Cardiol 2005 38 245 56
215. Xuan YT Guo Y Han H Zhu Y Bolli R An essential role of the JAK-STAT pathway in ischemic preconditioning Proc Natl Acad Sci USA 2001 98 9050 55
216. Xuan YT Tang XL Banerjee S Takano H Li RC Han H Qiu Y Li JJ Bolli R Nuclear factor κB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits Circ Res 1999 84 1095 1109
217. Yamashita N Nishida M Hoshida S Kuzuya T Hori M Taniguchi N Kamada T Tada M Induction of manganese superoxide dismutase in rat cardiac myocytes increases tolerance to hypoxia 24 hours after preconditioning J Clin Invest 1994 94 2193 99
218. Yellon DM Downey JM Preconditioning the myocardium: From cellular physiology to clinical cardiology Physiol Rev 2003 83 1113 51
219. Yllner S Metabolism of 1,1,2-trichloroethane-1,2-14C in the mouse Acta Pharmacol Toxicol 1971 30 248 56
220. Ytrehus K Liu Y Downey JM Preconditioning protects ischemic rabbit heart by protein kinase C activation Am J Physiol 1994 266 H1145 52
221. Yue TL Wang C Gu JL Ma XL Kumar S Lee JC Feuerstein GZ Thomas H Maleeff B Ohlstein EH Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart Circ Res 2000 86 692 99
222. Zanobetti A Schwartz J Particulate air pollution, progression, and survival after myocardial infarction Environ Health Perspect 2007 115 769 75
223. Zhang JG Ghosh S Ockleford CD Galiñanes M Characterization of an in vitro model for the study of the short and prolonged effects of myocardial ischaemia and reperfusion in man Clin Sci 2000 99 443 53
224. Zhao ZQ Corvera JS Halkos ME Kerendi F Wang NP Guyton RA Vinten-Johansen J Inhibition of myocardial injury by ischemic postconditioning during reperfusion: Comparison with ischemic preconditioning Am J Physiol 2003 285 H579 88
225. Zhu M Feng J Lucchinetti E Fischer G Xu L Pedrazzini T Schaub MC Zaugg M Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway Cardiovasc Res 2006 72 152 62